Biomedical Innovation
Advances in medicine and the life sciences — in genetics, artificial intelligence, cell engineering, etc — continually push the boundaries of what is possible, sometimes outpacing existing regulations and ethical guidelines. Striking a balance between promoting innovation and protecting patients and the public is an ongoing challenge.
Examples of LML research in this field can be found below:
Patents
M Aboy, K Foss-Solbrekk, T Minssen, The Unified Patent Court’s approach to inventive step, Journal of Intellectual Property Law & Practice, (2026), https://doi.org/10.1093/jiplp/jpag069
K Foss-Solbrekk, M Aboy, T Minssen, Balancing Disclosure and Protection: Plausibility after G 2/21, GRUR International, 75(6), 511–521 (2026) https://doi.org/10.1093/grurint/ikag037
G Lenarczyk, T Minssen & M Aboy, IP in Superposition: Patents, Trade Secrets and Open Innovation in Quantum Information Technology, in Quantum Technology Governance: Law, Policy and Ethics in the Quantum Era (Springer, forthcoming 2025/2026) https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5363171
M Aboy, K Liddell & A Lath, Inventorship in the age of AI: examining the USPTO Guidance on AI-assisted inventions, 20(7) Journal of Intellectual Property Law & Practice (2025), https://doi.org/10.1093/jiplp/jpaf019
J Liddicoat, A Hamidzadeh, K Liddell & M Aboy, How many drugs are repositioned each year in Europe?, 28(1) The Journal of World Intellectual Property (2025), https://onlinelibrary.wiley.com/doi/pdf/10.1111/jwip.12327
Regulatory exclusivities
J Liddicoat, K Liddell, J Darrow, M Aboy, M Jordan, C Crespo, T Minssen, ‘Repositioning Generic Drugs: Empirical Findings and Policy Implications’ (2022) 53(9) International Review of Intellectual Property and Competition Law 1287.
J Liddicoat, K Liddell, M Aboy and J Wested, “Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the “+1” Regulatory Exclusivity” (2021) 52(7) International Review of Intellectual Property and Competition Law 825.
V Van de Wiele, J Darrow and A S Kesselheim, “No Parking Here: A Review of Generic Drug 180-Day Exclusivity and Recent Reform Proposals” (2021) 20(1) Yale Journal of Health Policy, Law, and Ethics 1.